{
  "input": {
    "mode": "build_chain",
    "query": {
      "entity": "Primary membranoproliferative glomerulonephritis",
      "relation": "indication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_rituximab",
          "name": "Rituximab"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_eculizumab",
          "name": "Eculizumab"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_mycophenolate_mofetil",
          "name": "Mycophenolate mofetil"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_cyclophosphamide",
          "name": "Cyclophosphamide"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_tacrolimus",
          "name": "Tacrolimus"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_prednisone",
          "name": "Prednisone"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_azathioprine",
          "name": "Azathioprine"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_sirolimus",
          "name": "Sirolimus"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_plasma_exchange",
          "name": "Plasma exchange"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_bortezomib",
          "name": "Bortezomib"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_belimumab",
          "name": "Belimumab"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_dexamethasone",
          "name": "Dexamethasone"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "tegraph_snapshot": {
      "nodes": [],
      "edges": [],
      "round_index": 1
    },
    "constraints": {
      "require_disjoint_paths": 2,
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "graph_updates": {
      "add_nodes": [
        {
          "id": "drug_rituximab",
          "type": "Drug",
          "label": "Rituximab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_eculizumab",
          "type": "Drug",
          "label": "Eculizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_mycophenolate_mofetil",
          "type": "Drug",
          "label": "Mycophenolate mofetil",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_cyclophosphamide",
          "type": "Drug",
          "label": "Cyclophosphamide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_tacrolimus",
          "type": "Drug",
          "label": "Tacrolimus",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_prednisone",
          "type": "Drug",
          "label": "Prednisone",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_azathioprine",
          "type": "Drug",
          "label": "Azathioprine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_sirolimus",
          "type": "Drug",
          "label": "Sirolimus",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_plasma_exchange",
          "type": "Drug",
          "label": "Plasma exchange",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_bortezomib",
          "type": "Drug",
          "label": "Bortezomib",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_belimumab",
          "type": "Drug",
          "label": "Belimumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_dexamethasone",
          "type": "Drug",
          "label": "Dexamethasone",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "disease_primary_membranoproliferative_glomerulonephritis",
          "type": "Disease",
          "label": "Primary membranoproliferative glomerulonephritis",
          "attrs": {
            "agent": "Proponent"
          }
        }
      ],
      "add_edges": [
        {
          "source": "drug_rituximab",
          "target": "disease_primary_membranoproliferative_glomerulonephritis",
          "relation": "supports",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "已有研究表明 Rituximab 能改善某些类型的肾小管病"
        },
        {
          "source": "drug_eculizumab",
          "target": "disease_primary_membranoproliferative_glomerulonephritis",
          "relation": "supports",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "Eculizumab 对单抗相关肾病有效"
        },
        {
          "source": "drug_mycophenolate_mofetil",
          "target": "disease_primary_membranoproliferative_glomerulonephritis",
          "relation": "supports",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "已用于多种免疫介导条件下的肾脏病"
        },
        {
          "source": "drug_cyclophosphamide",
          "target": "disease_primary_membranoproliferative_glomerulonephritis",
          "relation": "supports",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "常用于系统性疾病导致的肾小管病"
        },
        {
          "source": "drug_tacrolimus",
          "target": "disease_primary_membranoproliferative_glomerulonephritis",
          "relation": "supports",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "Tacrolimus 在肾移植患者中有效"
        },
        {
          "source": "drug_prednisone",
          "target": "disease_primary_membranoproliferative_glomerulonephritis",
          "relation": "supports",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "经典的免疫抑制治疗"
        },
        {
          "source": "drug_azathioprine",
          "target": "disease_primary_membranoproliferative_glomerulonephritis",
          "relation": "supports",
          "weight": 0.4,
          "agent": "Proponent",
          "rationale": "有助于抑制自身免疫反应"
        },
        {
          "source": "drug_sirolimus",
          "target": "disease_primary_membranoproliferative_glomerulonephritis",
          "relation": "supports",
          "weight": 0.4,
          "agent": "Proponent",
          "rationale": "可能对特定肾病类型有效"
        },
        {
          "source": "drug_plasma_exchange",
          "target": "disease_primary_membranoproliferative_glomerulonephritis",
          "relation": "supports",
          "weight": 0.45,
          "agent": "Proponent",
          "rationale": "在重症患者中使用此疗法"
        },
        {
          "source": "drug_bortezomib",
          "target": "disease_primary_membranoproliferative_glomerulonephritis",
          "relation": "supports",
          "weight": 0.35,
          "agent": "Proponent",
          "rationale": "对特定类型的病理有效"
        },
        {
          "source": "drug_belimumab",
          "target": "disease_primary_membranoproliferative_glomerulonephritis",
          "relation": "supports",
          "weight": 0.3,
          "agent": "Proponent",
          "rationale": "影响B淋巴细胞，可能改善病情"
        },
        {
          "source": "drug_dexamethasone",
          "target": "disease_primary_membranoproliferative_glomerulonephritis",
          "relation": "supports",
          "weight": 0.4,
          "agent": "Proponent",
          "rationale": "类固醇在免疫介导病中有效"
        }
      ]
    },
    "subconclusions": [
      {
        "id": "C1",
        "text": "多种药物可能对原发性增殖性肾小管炎病情有积极影响",
        "confidence": "medium"
      }
    ],
    "assumptions": [
      "假定所列药物可有效达到肾脏并产生作用"
    ],
    "uncertainties": [
      "不同类别药物的联合疗效仍需临床验证"
    ],
    "next_focus_for_pi": [
      "是否需要进一步探索具体临床试验的数据支持？"
    ]
  }
}